NATUREX Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
31.01.2016
|
Total number of outstanding shares forming the capital - 9,238,850 ordinary shares under ISIN FR0000054694 - 2,690 shares issued from stock-options under ISIN FR0000054694 | 9,241,540 |
| Number of shares with double voting rights | 2,099,889 |
| Total number of gross voting rights | 11,341,429 |
|
Number of shares without voting rights - 3,918 bearer shares in the frame of the liquidity contract | - 3,918 |
| Total number of exercisable voting rights* | 11,337,511 |
*Exercisable voting rights = total number of voting rights – number of shares without voting rights
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
Financial schedule
| Results – FY 2015 | 30 March 2016 |
Upcoming events
| SFAF Analysts Meeting General Meeting |
31 March 2016 21 June 2016 |
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,241,540 (Janvier 2016)
ISIN FR0000054694
Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,500 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
| Contacts | |
| Carole Alexandre Head of Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com | Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Information relative au nombre total de droits de vote et d′actions composant le capital :
-
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-43098-2016.02.11-Nb-of-shares-and-voting-rights_January-2016.pdf
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it′s free
© 2016 ActusNews
